Halberd CorpOTC Pink - Current Information:HALB
- LAST PRICE0.0084
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0084 / 0.0084
- Day Range
- 52 Week Range
- Volume1,609,419
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | HALB |
|---|---|---|
| 09:32 ET | 100 | 0.0084 |
| 09:57 ET | 1000 | 0.00805 |
| 10:10 ET | 72000 | 0.0084 |
| 10:19 ET | 61309 | 0.0084 |
| 10:24 ET | 113910 | 0.0084 |
| 10:35 ET | 1000 | 0.00848 |
| 12:02 ET | 500000 | 0.0085 |
| 03:20 ET | 178000 | 0.0081 |
| 03:30 ET | 100 | 0.0085 |
| 03:54 ET | 4000 | 0.00865 |
| 03:56 ET | 678000 | 0.008395 |
Apr 4, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Halberd Corp | 5.3M | 3.6x | --- |
Manuka Inc | 5.6M | -3.9x | --- |
Silo Pharma Inc | 5.4M | -1.6x | --- |
Lipella Pharmaceuticals Inc | 4.9M | -0.9x | --- |
Oragenics Inc | 5.5M | -0.1x | --- |
Altamira Therapeutics Ltd | 3.7M | 0.0x | --- |
Company Information
Halberd Corporation is a holding company. The Company is engaged in the acquisition vehicle for established businesses. It is also developing treatments for neurodegenerative diseases, such as post-traumatic stress disorder/chronic traumatic encephalopathy (PTSD/ CTE), Alzheimer’s disease and Parkinson’s disease. It has two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and cerebrospinal fluid related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other viruses. Its Sequential Dialysis Technique is a methodology that physically removes the pathophysiologic basis of the disease, eliminating it without side effects. The Company’s wholly owned subsidiary is Alaric Corporation.
Contact Information
- Headquarters
- P.O. Box 25JACKSON CENTER, PA, United States 16133
- Phone
- ---
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.3M |
|---|---|
Revenue (TTM) | $281.2K |
Shares Outstanding | 635.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -3.76 |
EPS | $0.00 |
Book Value | $0.00 |
P/E Ratio | 3.6x |
Price/Sales (TTM) | 19.0 |
Price/Cash Flow (TTM) | 210.4x |
Operating Margin | 34.12% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
